Treatment of Oncological Patient in Terminal Stage with Two Different Hemodialysis - Case Report
- *Corresponding Author:
- Simona E Cioinac
UO-Dialysis, CAL Bentivoglio
AUSL di Bologna, Italy
Tel: + 3494370660
E-mail: [email protected]
Received date: June 13, 2016; Accepted date: July 11, 2016; Published date: July 12, 2016
Citation: Cioinac S, Lavalle T (2016) Treatment of Oncological Patient in Terminal Stage with Two Different Hemodialysis - Case Report. J Clin Res Bioeth 7:1000278. doi:10.4172/2155-9627.1000278
Copyright: © 2016 Cioinac S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Background: The number of patients with oncological diseases in hemodialysis is sharply increasing. These patients require hemodialysis and a personalized care that improves the tolerability, management of complications, pain, anxiety and fear of the patient and family. The literature presents approaches in different oncological diseases but there is still a dialysis treatment that allows greater tolerability. In this article, we describe the alternation of two different treatments and highlight the necessity of a personalized care process.
Case Presentation: Patient diagnosed with ovarian cancer, after countless series of complications, in the terminal phase requires service and haemodialysis customized. Prescribed treatment was: three treatments on-line hemodiafiltration of the duration 3:30 hours using monitors for intermittent haemodialysis. The fourth treatment catheter veno-venous hemodiafiltration of the duration 4 hours using monitors for continuous haemodialysis.
Conclusion: The case presented shows the need to identify a personalized care pathway for the management of cancer patients on haemodialysis and their families, good results. The alternation of the two treatments has allowed greater tolerance and fewer complications. This is just a clinical experience. Observational studies of RCTs (Random Trial Controls) could help clinics in understanding if the two alternate treatments can improve the quality of life, reduce pain and suffering.